WVE Wave Life Sciences Ltd

USD 6.04 0.38 6.713781
Icon

Wave Life Sciences Ltd (WVE) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 6.04

+0.38 (+6.71)%

USD 0.71B

0.41M

USD 10.00(+65.56%)

N/A

Icon

WVE

Wave Life Sciences Ltd (USD)
COMMON STOCK | NSD
USD 6.04
0.00 0
Take a Tour
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.71B

N/A

USD 6.04

Wave Life Sciences Ltd (WVE) Stock Forecast

Show ratings and price targets of :
USD 10.00
(+65.56%)

Based on the Wave Life Sciences Ltd stock forecast from 2 analysts, the average analyst target price for Wave Life Sciences Ltd is USD 10.00 over the next 12 months. Wave Life Sciences Ltd’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Wave Life Sciences Ltd is Slightly Bearish, which is based on 4 positive signals and 6 negative signals. At the last closing, Wave Life Sciences Ltd’s stock price was USD 6.04. Wave Life Sciences Ltd’s stock price has changed by -2.27% over the past week, +18.43% over the past month and +61.50% over the last year.

No recent analyst target price found for Wave Life Sciences Ltd
No recent average analyst rating found for Wave Life Sciences Ltd

Company Overview Wave Life Sciences Ltd

Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's RNA medicines platform, PRISM, combines multiple modalities, chemistry i...Read More

Marina One East Tower, Singapore, Singapore, 018936

266

December

USD

USA

Adjusted Closing Price for Wave Life Sciences Ltd (WVE)

Loading...

Unadjusted Closing Price for Wave Life Sciences Ltd (WVE)

Loading...

Share Trading Volume for Wave Life Sciences Ltd Shares

Loading...

Compare Performance of Wave Life Sciences Ltd Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for WVE

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Wave Life Sciences Ltd (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NVO
Novo Nordisk A/S -1.36 (-1.05%) USD554.45B 46.01 4.80

ETFs Containing WVE

Symbol Name WVE's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Wave Life Sciences Ltd (WVE) Stock

Based on ratings from 2 analysts Wave Life Sciences Ltd's stock is Buy . Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, sell and 1 hold ratings.

Unfortunately we do not have enough data on WVE's stock to indicate if its a good dividend stock.

Based on targets from 2 analysts, the average taret price for WVE is USD 10.00 over the next 12 months. The maximum analyst target price is USD 15 while the minimum anlayst target price is USD 5.

Unfortunately we do not have enough data on WVE's stock to indicate if its overvalued.

The last closing price of WVE's stock was USD 6.04.

The most recent market capitalization for WVE is USD 0.71B.

Based on targets from 2 analysts, the average taret price for WVE is projected at USD 10.00 over the next 12 months. This means that WVE's stock price may go up by +65.56% over the next 12 months.

We can't find any ETFs which contains Wave Life Sciences Ltd's stock.

As per our most recent records Wave Life Sciences Ltd has 266 Employees.

Wave Life Sciences Ltd's registered address is Marina One East Tower, Singapore, Singapore, 018936. You can get more information about it from Wave Life Sciences Ltd's website at https://www.wavelifesciences.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...